Employer: The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Center for Regenerative Medicine Location: Columbus, Ohio USA Salary: Commensurate with ability and experience. A…
Expanding use of CAR-T to include so-called second-line treatment for lymphoma would add approximately 11,000 to 14,000 eligible patients.
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Dec 11, 2021–
Building on an outstanding foundation, the Director of the Center for Reproductive Health Sciences is charged with developing and implementing an innovative and robust strategic vision for thefuture…
Where did dengue originate? The origin of dengue is unclear, but scientists have recently proposed that dengue originated in Asian forests in an infectious cycle involving mosquitoes and primates. As…
PDD as an approach to drug discovery and chemical biology has been building momentum and excitement in both academia and industry. The convergence of new technology platforms (e.g., induced…
Tessa Therapeutics is doing CAR-T a bit differently. After reading out some positive — albeit early — results back in May showing their virus-specific T cells (VSTs) achieved three partial responses…
Announcing new data from a long-term follow-up study, Bluebird bio (BLUE) said that 89% of β-thalassemia patients from a key Phase 3 trial remained transfusion-free after…
Margaret Koziel has bounced back and forth between academia and biotech throughout her career — and after 25 years, she has landed her first position as part of a biotech’s top brass. Koziel joined…
Days after reporting positive Phase III results for intranasal migraine med zavegepant, Biohaven chairman and CEO Vlad Coric is talking about marketing plans. It’s a month or more before Biohaven will…
